Published on:
March 6, 2026
If you have ever been referred for fertility investigations or begun exploring why your cycles feel irregular, there is a good chance your doctor has mentioned Day 3 hormone blood tests. Drawn on or around the third day of your menstrual cycle, these tests measure three critical hormones — follicle-stimulating hormone (FSH), luteinising hormone (LH) and estradiol (E2) — and together they offer a valuable window into ovarian reserve, hormonal balance and overall reproductive health. In this guide we explain exactly what each hormone does, why timing matters so much, and how to interpret your results with confidence.
Day 3 hormone blood tests are a routine panel of blood work typically performed on the second, third or fourth day of your menstrual cycle — day one being the first day of a full menstrual bleed. This narrow window is chosen because it captures your baseline hormone levels before the ovaries begin actively recruiting and developing follicles for that cycle. At this early stage, hormone concentrations are at their most stable and clinically meaningful, giving clinicians a clear snapshot of how your brain and ovaries are communicating.
The three hormones most commonly measured are FSH, LH and estradiol. Some clinics will also include anti-Müllerian hormone (AMH), though AMH can be drawn on any day of the cycle. Together, these markers help your doctor assess your ovarian reserve — essentially, the quantity and quality of eggs remaining — as well as identify hormonal imbalances that might affect ovulation or cycle regularity.
Day 3 testing is one of the first steps in a broader infertility work-up, but it is also used to monitor women approaching the perimenopause, those with irregular periods, and anyone considering egg freezing or assisted reproduction. The test itself is straightforward: a simple blood test drawn from a vein, usually first thing in the morning, with results available within a few days.
You might wonder why your doctor insists on such a specific testing window. Hormone levels fluctuate dramatically throughout the menstrual cycle. During the mid-cycle surge, for instance, LH can spike to ten times its baseline value, while estradiol rises progressively as follicles mature. Testing at these later points would tell you very little about baseline ovarian function.
By day 3, the previous cycle's corpus luteum has fully regressed and progesterone levels have fallen, signalling the pituitary gland to begin releasing FSH afresh. Estradiol is still low because no dominant follicle has yet been selected. This hormonal "reset" provides the cleanest possible reading. If your cycle is irregular and you are unsure which day you are on, your doctor may use an ultrasound scan to confirm early follicular-phase status before drawing blood.
It is worth noting that the acceptable window extends from day 2 to day 4 in most clinical guidelines. If you cannot attend on precisely day 3, attending on day 2 or day 4 generally yields comparable results. What matters is avoiding testing mid-cycle or in the luteal phase, where values would be misleading.
Follicle-stimulating hormone is produced by the anterior pituitary gland in the brain. As its name suggests, FSH stimulates the growth and maturation of ovarian follicles — the small fluid-filled sacs that each contain an immature egg. In the early follicular phase, a cohort of antral follicles responds to rising FSH, and one will eventually become the dominant follicle destined for ovulation.
On day 3, a normal FSH level is generally considered to be below 10 IU/L. Values between 10 and 15 IU/L may suggest a degree of diminished ovarian reserve, while levels above 15 IU/L often indicate that the ovaries are requiring significantly more stimulation to produce follicles. It is important to understand that a higher FSH does not necessarily mean pregnancy is impossible; rather, it signals that the body is working harder to recruit follicles, which can affect both natural conception and outcomes with assisted reproduction.
FSH levels can vary from cycle to cycle, so a single elevated reading should always be interpreted in context. Your clinician may recommend repeating the test in a subsequent cycle or combining it with an AMH level and an antral follicle count on ultrasound for a more complete picture of ovarian reserve.
Consistently elevated day 3 FSH can point to several scenarios: diminished ovarian reserve associated with age, premature ovarian insufficiency (POI), or the approach of perimenopause. In younger women, a high FSH warrants further investigation to rule out chromosomal causes or autoimmune conditions. Conversely, an unusually low FSH might suggest a problem at the level of the pituitary gland, such as hypogonadotropic hypogonadism, though this is much less common.
Luteinising hormone works in concert with FSH. It is also secreted by the pituitary gland and plays a pivotal role in triggering ovulation. The dramatic mid-cycle LH surge — typically occurring around day 12 to 14 of a 28-day cycle — causes the dominant follicle to rupture and release a mature egg. Beyond ovulation, LH supports the formation of the corpus luteum, which produces progesterone to prepare the uterine lining for potential implantation.
On day 3, LH levels are typically in the range of 5 to 20 mIU/mL and should sit relatively close to FSH levels. A roughly 1:1 ratio of FSH to LH is considered normal. When the ratio shifts and LH is significantly higher than FSH — for example, an LH:FSH ratio of 2:1 or greater — it may raise suspicion for polycystic ovary syndrome (PCOS). Women with PCOS often have tonically elevated LH, which can disrupt normal follicle development and ovulation.
That said, modern diagnostic criteria for PCOS (the Rotterdam criteria) do not require an abnormal LH:FSH ratio, so this finding alone is not diagnostic. It is one piece of the puzzle alongside clinical symptoms, ultrasound findings and other hormonal markers such as androgens.
Very low LH on day 3, particularly when paired with low FSH, may indicate hypothalamic or pituitary dysfunction. This can occur in women with significant weight loss, excessive exercise, high stress levels, or conditions such as hypothalamic amenorrhoea. In these cases, the brain is not sending adequate signals to the ovaries, and ovulation may cease entirely.
Estradiol is the most potent form of oestrogen and is primarily produced by the developing ovarian follicles. On day 3, estradiol levels should still be relatively low because significant follicular development has not yet occurred. A normal day 3 estradiol level is typically between 25 and 75 pg/mL (or roughly 90–275 pmol/L, depending on the laboratory's units).
An estradiol level that is already elevated on day 3 — generally above 80 pg/mL — can be a subtle but important red flag. High early estradiol may indicate that the ovaries have begun recruiting follicles prematurely, sometimes in response to a declining ovarian reserve. Critically, elevated estradiol can also artificially suppress FSH through negative feedback on the pituitary gland. This means your FSH might appear reassuringly normal even though ovarian reserve is actually diminished.
This is precisely why FSH and estradiol should always be interpreted together. A "normal" FSH of 8 IU/L alongside an estradiol of 100 pg/mL is more concerning than an FSH of 8 IU/L with an estradiol of 40 pg/mL. If estradiol is elevated, your clinician may suggest repeating the panel in a subsequent cycle or ordering additional tests such as AMH or an antral follicle count.
Conversely, very low estradiol levels on day 3 — especially alongside elevated FSH — can indicate significantly reduced ovarian function. This combination is commonly seen in women approaching menopause or those with premature ovarian insufficiency. Low estradiol can also contribute to symptoms such as vaginal dryness, hot flushes, mood changes and reduced bone density over time.
One of the most important things to understand about Day 3 hormone blood tests is that no single value should be interpreted in isolation. FSH, LH and estradiol interact in a delicate feedback loop, and their relationship to one another tells a more complete story than any individual number. Here is a simplified guide to common result patterns:
Day 3 hormone tests are often the starting point, not the finish line. Depending on your results, your doctor may recommend:
The combination of day 3 bloods, AMH and an antral follicle count is widely regarded as the gold standard for evaluating ovarian reserve and guiding decisions around fertility treatment.
Once your results are available, your doctor will discuss them with you in the context of your age, medical history, cycle patterns and reproductive goals. For many women, Day 3 results will be entirely normal and simply provide reassurance. For others, the results may prompt further investigation or a referral to a fertility specialist.
If diminished ovarian reserve is identified, it does not automatically mean that natural conception is off the table — but it may influence the urgency of your timeline and the type of fertility treatment recommended. Women with very high FSH or very low AMH, for example, may be counselled to consider assisted reproduction sooner rather than later, as ovarian reserve tends to decline with time.
For women not currently trying to conceive, Day 3 hormone testing can still offer valuable insight. Understanding your hormonal baseline empowers you to make informed decisions about family planning, egg freezing, or simply monitoring changes as you approach the perimenopause. Knowledge, in this context, truly is power.
It is also worth remembering that a single set of results is a snapshot, not a verdict. Hormone levels can fluctuate between cycles, and lifestyle factors such as stress, illness and significant weight changes can temporarily influence readings. If a result seems unexpected, repeating the test in a subsequent cycle is often the sensible next step before drawing firm conclusions.
Hormonal contraceptives suppress your natural hormone production, which means FSH, LH and estradiol results will not accurately reflect your baseline ovarian function while you are taking them. Most doctors recommend stopping hormonal contraception for at least one full natural cycle before having Day 3 bloods drawn. Speak to your GP for personalised advice on when to schedule testing.
If your cycles are very irregular or absent, your doctor can use a transvaginal ultrasound to assess the ovaries and confirm that you are in the early follicular phase before drawing blood. In some cases, a progestogen withdrawal bleed may be induced to create a predictable "day 1" from which to count. AMH, which is cycle-independent, can also be tested alongside.
Day 3 tests provide important information about ovarian reserve and hormonal balance, but they do not give a definitive "yes" or "no" on fertility. Many factors influence conception, including fallopian tube health, uterine anatomy, sperm quality and timing of intercourse. Day 3 results are best understood as one piece of a comprehensive fertility assessment rather than a standalone predictor.
There is no strict age requirement. Day 3 testing is routinely offered to women undergoing fertility investigations at any age. However, if you are over 35 and have been trying to conceive for six months without success — or over 40 and trying for three months — it is advisable to request baseline hormonal testing promptly. Younger women with risk factors such as a family history of early menopause, previous ovarian surgery or certain medical conditions may also benefit from earlier testing.
The test involves a standard venepuncture — a small needle is inserted into a vein, usually in the arm. Most people experience only brief, mild discomfort. The sample is sent to a laboratory and results are typically available within a few working days. No special preparation is needed, although some clinics prefer a fasting morning sample.
The information provided in this article is for educational purposes only and is based on NHS recommendations. It is not a substitute for professional medical advice. Always consult your doctor or a qualified healthcare provider for advice on medical conditions or treatments.
Our medical centre is at 36 Spital Square, E1 6DY, City of London.
